Federal Register - October 8, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
56272
Federal Register / Vol. 86, No. 193 / Friday, October 8, 2021 / Notices
1. Placement Authorization Form P1
2. Authorization for Medical, Dental, and Mental Health Care Form P2
3. Intakes Placement Checklist 4. Transfer Request Form P10A
5. Transfer Summary and Tracking formerly titled Transfer Request and Tracking Form Form P11
6. UC Portal Capacity Report Form P
12
7. Add New UC Form P13
8. ORR Transfer NotificationNotice of Transfer to Immigration and Customs Enforcements ICE Chief CounselChange of Address/
Change of Venue Form P14
Respondents: ORR grantee and contractor staff, other federal agencies.
ANNUAL BURDEN ESTIMATES
Average burden minutes per response
Annual total burden hours
Placement Authorization Form P1
Authorization for Medical, Dental, and Mental Health Care Form P2
Notice of Placement in a Restrictive Setting Form P4/4s
Long Term Foster Care Placement Memo Form P5
UC Referral Form P7
UC ReferralIntakes Placement Checklist Form P7
Care Provider Checklist for Transfers to Influx Care Facilities Form P8
Medical Checklist for Transfers Form P9A
Medical Checklist for Influx Transfers Form P9B
Transfer Request Form P10AGrantee Case Manager
Transfer Request Form P10AContractor Case Coordinator
Influx Transfer Request Form P10B
Transfer Summary and Tracking Form P11
Program Entity Form P12
UC Profile Form P13
ORR Transfer NotificationORR Notification to ICE Chief Counsel of Transfer of UC and Request to Change Address/Venue Form P14
Family Group Entity Form P15
Influx Transfer Manifest Form P16
Influx Transfer Manual and Prescreen Criteria Review Form P17
216
216
15
30
16
16
216
216
216
216
250
216
216
216
216
278
278
34
3
3,250
9
10
27
63
37
37
63
37
12
241
5
5
20
15
60
30
15
5
10
25
20
25
10
30
45
5,004
5,004
170
23
52,000
72
540
486
2,268
3,330
3,083
5,670
1,332
1,296
39,042
216
16
3
216
37
188
12
43,333
10
5
20
30
1,332
251
12
4,679,964
Estimated Annual Burden Hours Total
4,800,879
Authority: 6 U.S.C. 279; 8 U.S.C.
1232; Flores v. Reno Settlement Agreement, No. CV854544RJK C.D.
Cal. 1996.
Mary B. Jones, ACF/OPRE Certifying Officer.
FR Doc. 202121999 Filed 10721; 8:45 am BILLING CODE 418445P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration Docket No. FDA2019D1262
Surgical Staplers and Staples for Internal UseLabeling Recommendations; Guidance for Industry and Food and Drug Administration Staff; Availability AGENCY:
Food and Drug Administration,
HHS.
jspears on DSK121TN23PROD with NOTICES1
Annual number of responses per respondent
Annual number of respondents
Instrument
ACTION:
Notice of availability.
The Food and Drug Administration FDA, we, or Agency is announcing the availability of a final guidance entitled Surgical Staplers and Staples for Internal UseLabeling Recommendations. FDA is issuing this
SUMMARY:
VerDate Sep<11>2014
17:07 Oct 07, 2021
Jkt 256001
guidance to provide labeling recommendations for surgical staplers and staples for internal use. These labeling recommendations are being issued because malfunctions and misuse associated with these devices have resulted in serious adverse events, including deaths.
DATES: The announcement of the guidance is published in the Federal Register on October 8, 2021.
ADDRESSES: You may submit either electronic or written comments on Agency guidances at any time as follows:
anyone elses Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https www.regulations.gov.
If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed see Written/Paper Submissions and Instructions.
Electronic Submissions Submit electronic comments in the following way:
Federal eRulemaking Portal:
https www.regulations.gov. Follow the instructions for submitting comments.
Comments submitted electronically, including attachments, to https
www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or
Written/Paper Submissions
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier for written/paper submissions: Dockets Management Staff HFA305, Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in Instructions.
E:FRFM08OCN1.SGM
08OCN1
